Effectiveness and Safety of Convalescent Plasma Therapy on COVID-19 Patients With Acute Respiratory Distress Syndrome

NCT04380935 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

UNKNOWN

Status

60

Enrollment

OTHER

Sponsor class

Conditions

COVID
Acute Respiratory Distress Syndrome

Interventions

BIOLOGICAL: Convalescent plasma
DRUG: Standard of care

Sponsor

Indonesia University

Collaborators

[object Object]
[object Object]